Pennacchio L A, Lehesjoki A E, Stone N E, Willour V L, Virtaneva K, Miao J, D'Amato E, Ramirez L, Faham M, Koskiniemi M, Warrington J A, Norio R, de la Chapelle A, Cox D R, Myers R M
Department of Genetics, Stanford University School of Medicine, Standford, CA 94305, USA.
Science. 1996 Mar 22;271(5256):1731-4. doi: 10.1126/science.271.5256.1731.
Progressive myoclonus epilepsy of the Unverricht-Lundborg type (EPM1) is an autosomal recessive inherited form of epilepsy, previously linked to human chromosome 21q22.3. The gene encoding cystatin B was shown to be localized to this region, and levels of messenger RNA encoded by this gene were found to be decreased in cells from affected individuals. Two mutations, a 3' splice site mutation and a stop codon mutation, were identified in the gene encoding cystatin B in EPM1 patients but were not present in unaffected individuals. These results provide evidence that mutations in the gene encoding cystatin B are responsible for the primary defect in patients with EPM1.
昂韦里希特-伦德伯格型进行性肌阵挛癫痫(EPM1)是一种常染色体隐性遗传的癫痫类型,此前与人类21号染色体q22.3区域相关联。编码胱抑素B的基因被证明定位于该区域,并且发现该基因编码的信使核糖核酸水平在患病个体的细胞中降低。在EPM1患者编码胱抑素B的基因中鉴定出两种突变,一种是3'剪接位点突变,另一种是终止密码子突变,而在未患病个体中不存在这些突变。这些结果提供了证据,证明编码胱抑素B的基因中的突变是EPM1患者原发性缺陷的原因。